(Bio)Pharmaceuticals
In the fast-moving world of (bio)pharmaceuticals, innovation is everything. Protecting your intellectual property, navigating complex regulations and structuring the right commercial agreements are critical to attracting investment, enabling growth and bringing life-changing therapies to market. Early, strategic legal advice can make the difference between a successful venture that advances a new drug to clinical trials and on to market and a missed opportunity.
Legal advice for (bio)pharmaceutical start-ups and scale-ups
Combining intellectual property, commercial, regulatory and legal advice, our team helps (bio)pharmaceutical innovators maximize business value and investment potential. Stratiphy offers one cohesive team, tailored to your company’s needs, delivering joined-up thinking across every stage of your journey
“Mark Lubbock is a high-level operator and tremendously impressive in negotiations.”
Services offered
Leveraging cross-disciplinary collaboration and integrated thinking, we provide comprehensive services spanning a wide range of fields:
IP strategy development and optimization
Proactive advice on patents and exclusivity
Leveraging IP and exit strategies
Commercial agreements
Competitor monitoring and litigation support
Our innovative combination of experienced specialists
Our advisors bring together a wealth of experience in IP strategy and commercial law. We understand the importance of IP in both protecting future revenue streams and, in the nearer term, optimising your investment and collaboration potential. With deep sector knowledge and a practical approach, we help you navigate the complexities of the (bio)pharmaceutical landscape with confidence.
%20(1).png)
Discover our featured insights
Stay informed with the latest Consulting developments and the global IP landscape. Tune into our EIP Talks podcast, explore expert insights and browse our published articles and thought leadership, all designed to keep you ahead in the world of intellectual property.
Provisional Agreement Reached on the EU Pharma Package: Takeaways for Pharmaceutical Companies
Why competitor patent monitoring is critical to your drug development strategy
Antibody Patent Protection in Europe and the US: Navigating EPO and USPTO Differences
Make your bio(pharma) IP investment ready
The IP Lifecycle: From Innovation to Monetisation
In this episode of EIP Talks, Mark Lubbock and Ellen Keenan O'Malley, solicitors at EIP, explore the full lifecycle of intellectual property, from the initial spark of innovation to the commercialisation of ideas. They share practical insights into how we support clients through the challenges of protecting, developing and monetising IP.The conversation covers how clients typically engage with us, the importance of identifying and securing various forms of IP, and the legal strategies needed to navigate collaborations, ownership, and licensing. It also highlights the significance of well-drafted contracts, website compliance and investor readiness. Whether you're launching a new product, entering a partnership, or preparing for investment, this episode offers valuable guidance on building a strong IP foundation and turning innovation into commercial success.
Find your match
We work closely with clients, from C-suite to IP teams, to unlock the full potential of their intellectual property. Our integrated team of litigators, patent attorneys and commercial IP experts helps drive business growth by protecting and strategically leveraging patents.
Search by expertise, industry or location to find the right team for your business.